At this time of the year, respiratory diseases are a concern and occupy a prominent place in the news. While COVID-19 and flu are recurring topics of media discussion, other illnesses are also emerging as noteworthy. Recently, there have been outbreaks of Legionnaires Disease in various corners of the world.
Inflation, the cost of living, and medical expenses/insurance are hot-button issues in the US. As we move into the 2024 election cycle, they will likely occupy more time and attention in the media and campaign trail. One of the principal challenges facing consumers in the new year is a pending
The virological and epidemiological landscapes are changing rapidly, and both health professionals and informed business travelers will have to make decisions under rapidly evolving circumstances. Long considered a tropical disease confined to South America, MENA, and South Asia, Leishmaniasis has managed to expand its range over the last few years.
The holiday season is in full swing. In the United States, Thanksgiving 2023 set the record for the highest air travel day, with nearly 3 million screened travelers taking to the air the Wednesday before the holiday. Business travel is still ongoing, adding a layer of travelers to the landscape.
Over the last few weeks, we’ve been treated to some dire-sounding headlines about “Bed Bugs Outbreak in Paris” and a few other European cities. Allegations have been made that bed bugs have infested high-end hotels and are traveling home with visitors to that city. As bed bugs are a legitimate
Clovibactin seems to be an impressive new antibiotic, at least per current research results–As we move through the wake of the official COVID-19 pandemic, there’s a great deal of focus on new antiviral and antibiotic treatments in various forms. This interest has, in turn, spurred on a new round of
